Cargando…
Producing amyloid fibrils in vitro: A tool for studying AL amyloidosis
Amyloid light-chain (AL) amyloidosis is the second most common form of systemic amyloidosis which is characterized by a high level of mortality and no effective treatment to remove fibril deposition. This disorder is caused by malfunctioning of B-cells resulting in production of abnormal protein fib...
Autores principales: | Sizova, Daria V., Raiker, Steve, Lakheram, Deaneira, Rao, Vishwanatha, Proffitt, Andrew, Jmeian, Yazen, Voegtli, Walter, Batonick, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982448/ https://www.ncbi.nlm.nih.gov/pubmed/36875796 http://dx.doi.org/10.1016/j.bbrep.2023.101442 |
Ejemplares similares
-
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis
por: Nuvolone, Mario, et al.
Publicado: (2022) -
Dissection of the amyloid formation pathway in AL amyloidosis
por: Kazman, Pamina, et al.
Publicado: (2021) -
Medical Plants and Nutraceuticals for Amyloid-β Fibrillation Inhibition
por: Witter, Steffi, et al.
Publicado: (2018) -
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
por: Swuec, Paolo, et al.
Publicado: (2019) -
Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis
por: Radamaker, Lynn, et al.
Publicado: (2021)